Appeals Court Rules Gene Patents Eligible under US Law

The US Court of Appeals reversed the earlier decision in the case challenging Myriad's BRCA patents, saying that isolated DNA is patent eligible under US law.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories